// App-Quantinova.ai

e17120 : HAT1 as a target for the combination therapy with pazopanib and hyperthermia.

Researchers

Presenter

  • Chyong-Huey Lai

Principal Investigators

  • Chiao-Yun Lin

  • Angel Chao

Medical Centers

  • Department of Oncology, Chang Gung Memorial Hospital, Taoyuan, Taiwan

  • Gynecologic Cancer Research Center, Chang Gung Memorial Hospital and Department of Obstetrics and Gynecology, Chang Gung University College of Medicine, Taoyuan, Taiwan

Locations

  • Taiwan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Leiomyosarcoma

  • Neuroleptic malignant syndrome

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Pazopanib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved